Case Report: Identification of microduplication in the chromosomal 2p16.1p15 region in an infant suffering from pulmonary arterial hypertension

Front Cardiovasc Med. 2023 Oct 23:10:1219480. doi: 10.3389/fcvm.2023.1219480. eCollection 2023.

Abstract

This study reports the first case of a patient with chromosomal 2p16.1p15 microduplication syndrome complicated by pulmonary arterial hypertension (PAH). A female infant was admitted to the hospital suffering from dyskinesia and developmental delay, and conventional echocardiography revealed an atrial septal defect (ASD), which was not taken seriously or treated at that time. Two years later, preoperative right heart catheterization for ASD closure revealed a mean pulmonary artery pressure (mPAP) of 45 mmHg. The mPAP was reduced, and the condition was stabilized after drug therapy. A genomic copy number duplication (3×) of at least 2.58 Mb in the 2p16.1p15 region on the paternal chromosome was revealed. Multiple Online Mendelian Inheritance in Man (OMIM) genes are involved in this genomic region, such as BCL11A, EHBP1, FAM161A, PEX13, and REL. EHBP1 promotes a molecular phenotypic transformation of pulmonary vascular endothelial cells and is thought to be involved in the rapidly developing PAH of this infant. Collectively, our findings contribute to the knowledge of the genes involved and the clinical manifestations of the 2p16.1p15 microduplication syndrome. Moreover, clinicians should be alert to the possibility of PAH and take early drug intervention when facing patients with 2p16.1p15 microduplications.

Keywords: 2p16.1p15; copy number mutation; developmental delay; microduplication; pulmonary arterial hypertension.

Publication types

  • Case Reports

Grants and funding

All phases of this study were supported by grants from the Hunan Province Major Special Project (No. 2020SK1013), Hunan Provincial Health Commission Project (No. 20200483), National Natural Sciences Foundation of China (No. 81500041), and Changsha Natural Science Foundation (No. KQ220239).